Viewing Study NCT01711632


Ignite Creation Date: 2025-12-24 @ 9:25 PM
Ignite Modification Date: 2026-03-16 @ 8:40 PM
Study NCT ID: NCT01711632
Status: COMPLETED
Last Update Posted: 2025-10-20
First Post: 2012-10-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia
Sponsor:
Organization: